Home-immediately access 800+ free online publications. Download CD3WD (680 Megabytes) and distribute it to the 3rd World. CD3WD is a 3rd World Development private-sector initiative, mastered by Software Developer Alex Weir and hosted by GNUveau_Networks (From globally distributed organizations, to supercomputers, to a small home server, if it's Linux, we know it.)ar.cn.de.en.es.fr.id.it.ph.po.ru.sw

CLOSE THIS BOOKFact sheet No 108: Epidemic Dysentery - Revised October 1996 (WHO, 1996, 2 p.)
VIEW THE DOCUMENT(introduction...)
VIEW THE DOCUMENTEPIDEMIC DYSENTERY

EPIDEMIC DYSENTERY

Dysentery may be simply defined as diarrhoea containing blood. Although several organisms can cause dysentery, Shigella are the most important. Shigella dysenteriae type 1 (Sd1), also known as the Shiga bacillus, is the most virulent of the four serogroups of Shigella. Sd1 is the only cause of epidemic dysentery. In addition to bloody diarrhoea, the illness caused by Sd1 often includes abdominal cramps, fever and rectal pain. Less frequent complications of infection with Sd1 include sepsis, seizures, renal failure and the haemolytic uraemic syndrome. Approximately 5-15% of Sd1 cases are fatal.

Prevalence

Sd1 has caused epidemics of dysentery throughout the world. It caused a 4-year epidemic in Central America beginning in 1968 that resulted in more than 500 000 cases and at least 20 000 deaths. No epidemics have occurred in the region since then, but Sd1 continues to occur sporadically in the Western hemisphere. In Africa, epidemic dysentery due to Sd1 appeared in eastern Zaire in 1979 and has subsequently been confirmed in Angola, Burundi, Equatorial Guinea, Ethiopia, Kenya, Malawi, Mozambique, Rwanda, Sao Tom and Principe, South Africa, Swaziland, Tanzania, Uganda, Zambia, and Zimbabwe.

Transmission

Few studies have been done to determine how dysentery is spread. The most likely modes of transmission are person-to-person contact, and contaminated water and food. Epidemics of Sd1 usually occur in impoverished areas. They affect people of all ages, with the highest age-specific incidence occurring among adults and the highest case fatality rates occurring among children.

Antimicrobial Resistance

A major obstacle to the control of Sd1 is its resistance to many antimicrobial drugs. In one central African country the bacillus was resistant to all oral antibiotics that were locally available. Furthermore, Sd1 can quickly develop resistance. Antibiotics are often effective against it for only one or two years after being introduced; resistance has even been observed to develop during the course of an epidemic. As resistance to commonly available antibiotics becomes more prevalent, alternative antibiotics are needed which are more expensive and more difficult to procure.

Treatment

During an epidemic, all dysentery patients should receive an antibiotic to which Sd1 from local cases has been shown to be sensitive. Dehydration should be treated with oral rehydration salts or, if severe, with intravenous fluids. Urgent efforts should be made to obtain enough antimicrobials to treat all patients, but if in short supply they should be reserved for those at highest risk of secondary complications and death. These would include children under five years of age, adults older than 50 years, patients presenting with dehydration, and those with serious underlying conditions such as malnutrition. Patients should be identified as early as possible so that treatment can be initiated with a minimum of delay.

Epidemic Control and Preventive Measures

Early detection and notification of epidemic dysentery, especially among adults, allows for timely mobilization of resources needed for appropriate case management and control. National and peripheral-level laboratories should be strengthened so they can reliably confirm Sd1 as the cause of an outbreak. Rectal swabs from suspected cases should be collected and shipped refrigerated to laboratories in an appropriate medium for culture to confirm the diagnosis of Sd1.

Laboratories should also be able to determine antimicrobial sensitivity patterns of Sd1 so that rational policies for the use of antimicrobials may be developed. Such policies should consider the antimicrobial sensitivity of local Sd1 strains and the availability and cost of effective antimicrobials. Testing of Sd1 isolates for antimicrobial sensitivity should be done at regular intervals to determine whether treatment guidelines remain appropriate. International referral laboratories are available to assist in identification of the organism and confirmation of the anti-microbial resistance pattern.

Health education efforts should promote improved personal, domestic, and environmental hygiene. This includes hand washing with soap after defecation and before handling food, use of clean drinking water, safe practices for preparing and storing food, and safe disposal of faeces.

The publication AGuidelines for the control of epidemics due to Shigella dysenteriae type 1” is available from the Distribution and Sales Unit, of WHO.

For further information, please contact, Division of Emerging and other Communicable Diseases Surveillance and Control WHO, Geneva (41 22) 791 2662. Fax (41 22) 791 4893.

All WHO Press Releases, Facts Sheets and Features can be obtained on Internet on the WHO home page http://www.who.ch/

TO PREVIOUS SECTION OF BOOK